Deep Genomics will use the money to advance drug candidates created through its AI drug development model, based on research by Toronto faculty.

The funding will make up part of a round expected to close at $500m in the next two months and valued the food listings and ordering platform at $3bn.

Access Industries invested in the data simplification software producer as part of a round that lifted its overall funding to $300m and its valuation above $1bn.

Qualcomm Ventures took part in a series D round that hiked the valuation of the electric scooter rental service from $250m to $450m.

Lilly Asia Ventures took part in a series B-plus round that marks the first for biopharmaceutical company Transcenta Holding, formed through the merger of two of the corporate's portfolio companies.

WuXi AppTec and New World Development-backed Adagene has now raised $155m in total, as it takes its first cancer immunotherapy through clinical testing.

The avatar software provider has ramped up its series B round to $40m, adding Salesforce Ventures to a consortium that already included Daimler.

Bloomberg Beta-backed Deep Genomics will use the series B funding to advance drug candidates created through its artificial intelligence drug development model.

VIPKid investor Tencent has participated in an $80m series A round for its livestreamed tutoring offshoot, Dami Wangxiao.

The medical data analytics platform has raised $5m from Merck Global Health Innovation Fund, adding to $23m raised last year.